Global Facial Injectable Market Research Report 2023

Report ID: 1993290 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Facial Injectable Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Hyaluronic Acid
        1.2.3 Collagen
        1.2.4 Botulinum Toxin
        1.2.5 Polymers
        1.2.6 Particles
    1.3 Market by Application
        1.3.1 Global Facial Injectable Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Research
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Facial Injectable Market Perspective (2017-2028)
    2.2 Facial Injectable Growth Trends by Region
        2.2.1 Facial Injectable Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Facial Injectable Historic Market Size by Region (2017-2022)
        2.2.3 Facial Injectable Forecasted Market Size by Region (2023-2028)
    2.3 Facial Injectable Market Dynamics
        2.3.1 Facial Injectable Industry Trends
        2.3.2 Facial Injectable Market Drivers
        2.3.3 Facial Injectable Market Challenges
        2.3.4 Facial Injectable Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Facial Injectable Players by Revenue
        3.1.1 Global Top Facial Injectable Players by Revenue (2017-2022)
        3.1.2 Global Facial Injectable Revenue Market Share by Players (2017-2022)
    3.2 Global Facial Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Facial Injectable Revenue
    3.4 Global Facial Injectable Market Concentration Ratio
        3.4.1 Global Facial Injectable Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Facial Injectable Revenue in 2021
    3.5 Facial Injectable Key Players Head office and Area Served
    3.6 Key Players Facial Injectable Product Solution and Service
    3.7 Date of Enter into Facial Injectable Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Facial Injectable Breakdown Data by Type
    4.1 Global Facial Injectable Historic Market Size by Type (2017-2022)
    4.2 Global Facial Injectable Forecasted Market Size by Type (2023-2028)
5 Facial Injectable Breakdown Data by Application
    5.1 Global Facial Injectable Historic Market Size by Application (2017-2022)
    5.2 Global Facial Injectable Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Facial Injectable Market Size (2017-2028)
    6.2 North America Facial Injectable Market Size by Country (2017-2022)
    6.3 North America Facial Injectable Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Facial Injectable Market Size (2017-2028)
    7.2 Europe Facial Injectable Market Size by Country (2017-2022)
    7.3 Europe Facial Injectable Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Facial Injectable Market Size (2017-2028)
    8.2 Asia-Pacific Facial Injectable Market Size by Country (2017-2022)
    8.3 Asia-Pacific Facial Injectable Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Facial Injectable Market Size (2017-2028)
    9.2 Latin America Facial Injectable Market Size by Country (2017-2022)
    9.3 Latin America Facial Injectable Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Facial Injectable Market Size (2017-2028)
    10.2 Middle East & Africa Facial Injectable Market Size by Country (2017-2022)
    10.3 Middle East & Africa Facial Injectable Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bloomega BioTechnology
        11.1.1 Bloomega BioTechnology Company Detail
        11.1.2 Bloomega BioTechnology Business Overview
        11.1.3 Bloomega BioTechnology Facial Injectable Introduction
        11.1.4 Bloomega BioTechnology Revenue in Facial Injectable Business (2017-2022)
        11.1.5 Bloomega BioTechnology Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Detail
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Facial Injectable Introduction
        11.2.4 Allergan Revenue in Facial Injectable Business (2017-2022)
        11.2.5 Allergan Recent Development
    11.3 Merz Pharma
        11.3.1 Merz Pharma Company Detail
        11.3.2 Merz Pharma Business Overview
        11.3.3 Merz Pharma Facial Injectable Introduction
        11.3.4 Merz Pharma Revenue in Facial Injectable Business (2017-2022)
        11.3.5 Merz Pharma Recent Development
    11.4 Bausch Health
        11.4.1 Bausch Health Company Detail
        11.4.2 Bausch Health Business Overview
        11.4.3 Bausch Health Facial Injectable Introduction
        11.4.4 Bausch Health Revenue in Facial Injectable Business (2017-2022)
        11.4.5 Bausch Health Recent Development
    11.5 Galderma
        11.5.1 Galderma Company Detail
        11.5.2 Galderma Business Overview
        11.5.3 Galderma Facial Injectable Introduction
        11.5.4 Galderma Revenue in Facial Injectable Business (2017-2022)
        11.5.5 Galderma Recent Development
    11.6 Integra Lifesciences
        11.6.1 Integra Lifesciences Company Detail
        11.6.2 Integra Lifesciences Business Overview
        11.6.3 Integra Lifesciences Facial Injectable Introduction
        11.6.4 Integra Lifesciences Revenue in Facial Injectable Business (2017-2022)
        11.6.5 Integra Lifesciences Recent Development
    11.7 Tei Biosciences
        11.7.1 Tei Biosciences Company Detail
        11.7.2 Tei Biosciences Business Overview
        11.7.3 Tei Biosciences Facial Injectable Introduction
        11.7.4 Tei Biosciences Revenue in Facial Injectable Business (2017-2022)
        11.7.5 Tei Biosciences Recent Development
    11.8 Fibrogen
        11.8.1 Fibrogen Company Detail
        11.8.2 Fibrogen Business Overview
        11.8.3 Fibrogen Facial Injectable Introduction
        11.8.4 Fibrogen Revenue in Facial Injectable Business (2017-2022)
        11.8.5 Fibrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Facial Injectable Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Hyaluronic Acid
    Table 3. Key Players of Collagen
    Table 4. Key Players of Botulinum Toxin
    Table 5. Key Players of Polymers
    Table 6. Key Players of Particles
    Table 7. Global Facial Injectable Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Facial Injectable Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Facial Injectable Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Facial Injectable Market Share by Region (2017-2022)
    Table 11. Global Facial Injectable Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Facial Injectable Market Share by Region (2023-2028)
    Table 13. Facial Injectable Market Trends
    Table 14. Facial Injectable Market Drivers
    Table 15. Facial Injectable Market Challenges
    Table 16. Facial Injectable Market Restraints
    Table 17. Global Facial Injectable Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Facial Injectable Market Share by Players (2017-2022)
    Table 19. Global Top Facial Injectable Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Facial Injectable as of 2021)
    Table 20. Ranking of Global Top Facial Injectable Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Facial Injectable Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Facial Injectable Product Solution and Service
    Table 24. Date of Enter into Facial Injectable Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Facial Injectable Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Facial Injectable Revenue Market Share by Type (2017-2022)
    Table 28. Global Facial Injectable Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Facial Injectable Revenue Market Share by Type (2023-2028)
    Table 30. Global Facial Injectable Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Facial Injectable Revenue Market Share by Application (2017-2022)
    Table 32. Global Facial Injectable Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Facial Injectable Revenue Market Share by Application (2023-2028)
    Table 34. North America Facial Injectable Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Facial Injectable Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Facial Injectable Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Facial Injectable Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Facial Injectable Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Facial Injectable Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Facial Injectable Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Facial Injectable Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Facial Injectable Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Facial Injectable Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Bloomega BioTechnology Company Detail
    Table 45. Bloomega BioTechnology Business Overview
    Table 46. Bloomega BioTechnology Facial Injectable Product
    Table 47. Bloomega BioTechnology Revenue in Facial Injectable Business (2017-2022) & (US$ Million)
    Table 48. Bloomega BioTechnology Recent Development
    Table 49. Allergan Company Detail
    Table 50. Allergan Business Overview
    Table 51. Allergan Facial Injectable Product
    Table 52. Allergan Revenue in Facial Injectable Business (2017-2022) & (US$ Million)
    Table 53. Allergan Recent Development
    Table 54. Merz Pharma Company Detail
    Table 55. Merz Pharma Business Overview
    Table 56. Merz Pharma Facial Injectable Product
    Table 57. Merz Pharma Revenue in Facial Injectable Business (2017-2022) & (US$ Million)
    Table 58. Merz Pharma Recent Development
    Table 59. Bausch Health Company Detail
    Table 60. Bausch Health Business Overview
    Table 61. Bausch Health Facial Injectable Product
    Table 62. Bausch Health Revenue in Facial Injectable Business (2017-2022) & (US$ Million)
    Table 63. Bausch Health Recent Development
    Table 64. Galderma Company Detail
    Table 65. Galderma Business Overview
    Table 66. Galderma Facial Injectable Product
    Table 67. Galderma Revenue in Facial Injectable Business (2017-2022) & (US$ Million)
    Table 68. Galderma Recent Development
    Table 69. Integra Lifesciences Company Detail
    Table 70. Integra Lifesciences Business Overview
    Table 71. Integra Lifesciences Facial Injectable Product
    Table 72. Integra Lifesciences Revenue in Facial Injectable Business (2017-2022) & (US$ Million)
    Table 73. Integra Lifesciences Recent Development
    Table 74. Tei Biosciences Company Detail
    Table 75. Tei Biosciences Business Overview
    Table 76. Tei Biosciences Facial Injectable Product
    Table 77. Tei Biosciences Revenue in Facial Injectable Business (2017-2022) & (US$ Million)
    Table 78. Tei Biosciences Recent Development
    Table 79. Fibrogen Company Detail
    Table 80. Fibrogen Business Overview
    Table 81. Fibrogen Facial Injectable Product
    Table 82. Fibrogen Revenue in Facial Injectable Business (2017-2022) & (US$ Million)
    Table 83. Fibrogen Recent Development
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Facial Injectable Market Share by Type: 2021 VS 2028
    Figure 2. Hyaluronic Acid Features
    Figure 3. Collagen Features
    Figure 4. Botulinum Toxin Features
    Figure 5. Polymers Features
    Figure 6. Particles Features
    Figure 7. Global Facial Injectable Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Research Case Studies
    Figure 11. Others Case Studies
    Figure 12. Facial Injectable Report Years Considered
    Figure 13. Global Facial Injectable Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Facial Injectable Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Facial Injectable Market Share by Region: 2021 VS 2028
    Figure 16. Global Facial Injectable Market Share by Players in 2021
    Figure 17. Global Top Facial Injectable Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Facial Injectable as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Facial Injectable Revenue in 2021
    Figure 19. North America Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Facial Injectable Market Share by Country (2017-2028)
    Figure 21. United States Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Facial Injectable Market Share by Country (2017-2028)
    Figure 25. Germany Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Facial Injectable Market Share by Region (2017-2028)
    Figure 33. China Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Facial Injectable Market Share by Country (2017-2028)
    Figure 41. Mexico Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Facial Injectable Market Share by Country (2017-2028)
    Figure 45. Turkey Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Facial Injectable Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Bloomega BioTechnology Revenue Growth Rate in Facial Injectable Business (2017-2022)
    Figure 48. Allergan Revenue Growth Rate in Facial Injectable Business (2017-2022)
    Figure 49. Merz Pharma Revenue Growth Rate in Facial Injectable Business (2017-2022)
    Figure 50. Bausch Health Revenue Growth Rate in Facial Injectable Business (2017-2022)
    Figure 51. Galderma Revenue Growth Rate in Facial Injectable Business (2017-2022)
    Figure 52. Integra Lifesciences Revenue Growth Rate in Facial Injectable Business (2017-2022)
    Figure 53. Tei Biosciences Revenue Growth Rate in Facial Injectable Business (2017-2022)
    Figure 54. Fibrogen Revenue Growth Rate in Facial Injectable Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bloomega BioTechnology
Allergan
Merz Pharma
Bausch Health
Galderma
Integra Lifesciences
Tei Biosciences
Fibrogen
Frequently Asked Questions
Facial Injectable report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Facial Injectable report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Facial Injectable report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports